Background: Low treatment completion rate in tuberculosis (TB) patients is a major concern. Physicians have always been striving for better treatment adherence in such patients. The present study is one such attempt in this direction. Objectives: The study was aimed to evaluate the role of behavior modification by psychotherapy in improving compliance with short-course anti-TB chemotherapy in India. Methods: It was a prospective controlled trial involving patients with confirmed pulmonary and extrapulmonary TB enrolled in the National Tuberculosis Program. The intervention group underwent pretreatment psychological assessment followed by regular psychotherapy sessions. Results: The intervention group had a demographic profile comparable to that of the control group. The patients were mostly from low- and middle-income backgrounds from urban and semi-urban areas. They consistently showed poor knowledge about the nature of the disease, low motivation, and had considerable apprehensions. Following the sessions, the intervention group showed improved compliance compared with the control group, reflected in significantly higher treatment completion and cure rates. Conclusions: The study suggests that psychological intervention is effective in improving compliance with anti-TB treatment, and may reduce the incidence of treatment failure, relapse and drug resistance.

Keywords:
Psychotherapy, Compliance, Antituberculous chemotherapy
1.
Chaudhuri K, Jagota P, Parimala N: Result of treatment with a short course chemotherapy regimen used under field conditions in District Tuberculosis Program. Ind J Tuberc 1993;40:83–89.
2.
Suryanarayana L, Vembu K, Satayanarayana C, Rajalakshmi R: Status of short course chemotherapy under National Tuberculosis Programme. Ind J Tuberc 1994;41:211–221.
3.
Nazar-Stewart V, Nolan CM: Result of directly observed intermittent isoniazid preventive therapy programme in a shelter for homeless men. Am Rev Respir Dis 1992;146:57–60.
4.
Wobeser W, To T, Hoeppner VH: The outcome of chemoprophylaxis on tuberculosis prevention in Canadian Plains Indians. Clin Invest Med 1989;12:149–153.
5.
Becker MH: Theoretical model of adherence and strategies for improving adherence; in Schoemaker SA, Schron EB: The handbook of health behaviour changes. New York, Springer, 1990, pp 5–43.
6.
Cummings KM, Becker MH, Maile MC: Bring the models together: An empirical approach to combining variables used to explain health actions. J Behav Med 1980;3:123–145.
7.
Seetha MA, Rupert Samuel GE, Naidu VB: A study of some operational aspects of treatment cards in a district tuberculosis programme. Ind J Tuberc 1976;23:90–97.
8.
Meichen Baum D, Turk DC: Facilitating Treatment Adherence. A Practitioner Guide Book. New York, Plenum Press, 1987.
9.
Berger HW, Mejia E: Tuberculous pleurisy. Chest 1973;63:88–92.
10.
Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Talley M: Randomised controlled trial of self supervised and directly observed treatment of tuberculosis. Lancet 1998;352:1340–1343.
11.
Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–296.
12.
Prochaska, JO, DiClemente CC: Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psy 1983;51:390–395.
13.
Grazzini M,Ottanelli R, Duranti R, Stendardi L, Ronchi MC, Roma I, Scano G: Measures of perception of bronchoconstriction and clinical and functional data are not interrelated in asthma. Respiration 2002;69:496–501.
14.
Randerath WJ, Gerdesmeyer C, Siller K, Gil G, Sanner B, Ruhle K: A test for the determination of sustained attention in patients with obstructive sleep apnea syndrome. Respiration 2000;67:526–532.
15.
Lemanek K: Adherence issues in the medical management of asthma. J Pediatr Psychol 1990;15:437–458.
16.
Munzenberger PJ: Improving adherence in patients with asthma. Am Pharm 1993;NS33:32–37.
17.
Brooks CM, Richards JM, Kohler CL, Soong SJ, Martin B, Windsor RA, Bailey WC: Assessing adherence to asthma medication and inhaler regimens: A psychometric analysis of adult self-report scales. Med Care 1994;32:298–307.
18.
Rand CS, Wise RA: Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994:149:S69–78.
19.
Allen EA, Stewart M, Penny P: The efficacy of post-sanatorium management in tuberculosis: Can J Public Health 1964;55:323.
20.
Zaki MH, Edelstein S, Josephson RA, Weisberg SR: Regularity of drug administration among hospitalized and ambulatory tuberculosis patients. Am Rev Resp Dis 1968;97:136–139.
21.
Gordis L, Markowitz M, Lilienfeld AM: Why patients don’t follow medical advice: A study of children on long-term antistreptococcal prophylaxis. J Pediatr 1969;75:957–968.
22.
Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL: Patient compliance with antihypertensive regimens. Patient Couns Health Educ 1978;1:18–21.
23.
Kelloway JS, Wyatt RA, Adlis SA: Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349–1352.
24.
Eney RD, Goldstein EO: Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics 1976;57:513–517.
25.
Wood PR, Casey R, Kolski GB, McCormick MC: Compliance with oral theophylline therapy in asthmatic children. Ann Allergy 1985;54:400–404.
26.
Suhadev M, Ganapathy S, Sivasubramanium S, Devi TS: A retrospective study of ‘non-compliant’ patients in controlled clinical trials of short course chemotherapy. Ind J Tuberc 1995;42:221–224.
27.
Seetha MA, Srikantaramu N, Aneja KS, Singh H: Influence of motivation of patients and their family members on the drug collection by patients. Ind J Tuberc 1981;28:182–190.
28.
Uplekar M, Rangan S: Alternative approaches to improvement in treatment adherence in tuberculosis control programme. Ind J Tuberc 1995;42:67–74.
29.
Charles N: Influence of initial and repeated motivation on case-holding in North Arcot district. Ind J Tuberc 1991;38:69–71.
30.
Verma SK: Construction and Standardization of PGI Health Questionnaire N-2. Agra, Agra Psychological Research Cell, 1978, pp 1–135.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.